154 related articles for article (PubMed ID: 11810277)
1. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.
Abraham R; Myers A; Wavrant-DeVrieze F; Hamshere ML; Thomas HV; Marshall H; Compton D; Spurlock G; Turic D; Hoogendoorn B; Kwon JM; Petersen RC; Tangalos E; Norton J; Morris JC; Bullock R; Liolitsa D; Lovestone S; Hardy J; Goate A; O'Donovan M; Williams J; Owen MJ; Jones L
Hum Genet; 2001 Dec; 109(6):646-52. PubMed ID: 11810277
[TBL] [Abstract][Full Text] [Related]
2. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
Nowotny P; Hinrichs AL; Smemo S; Kauwe JS; Maxwell T; Holmans P; Hamshere M; Turic D; Jehu L; Hollingworth P; Moore P; Bryden L; Myers A; Doil LM; Tacey KM; Gibson AM; McKeith IG; Perry RH; Morris CM; Thal L; Morris JC; O'Donovan MC; Lovestone S; Grupe A; Hardy J; Owen MJ; Williams J; Goate A
Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):62-8. PubMed ID: 15858813
[TBL] [Abstract][Full Text] [Related]
3. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.
Bertram L; Blacker D; Mullin K; Keeney D; Jones J; Basu S; Yhu S; McInnis MG; Go RC; Vekrellis K; Selkoe DJ; Saunders AJ; Tanzi RE
Science; 2000 Dec; 290(5500):2302-3. PubMed ID: 11125142
[TBL] [Abstract][Full Text] [Related]
4. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):87-91. PubMed ID: 14755451
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.
Prince JA; Feuk L; Gu HF; Johansson B; Gatz M; Blennow K; Brookes AJ
Hum Mutat; 2003 Nov; 22(5):363-71. PubMed ID: 14517947
[TBL] [Abstract][Full Text] [Related]
6. Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels.
Reitz C; Cheng R; Schupf N; Lee JH; Mehta PD; Rogaeva E; St George-Hyslop P; Mayeux R
Neurobiol Aging; 2012 Jan; 33(1):199.e13-7. PubMed ID: 20724036
[TBL] [Abstract][Full Text] [Related]
7. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease.
Ozturk A; DeKosky ST; Kamboh MI
Neurosci Lett; 2006 Oct; 406(3):265-9. PubMed ID: 16914266
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
Ertekin-Taner N; Allen M; Fadale D; Scanlin L; Younkin L; Petersen RC; Graff-Radford N; Younkin SG
Hum Mutat; 2004 Apr; 23(4):334-42. PubMed ID: 15024728
[TBL] [Abstract][Full Text] [Related]
10. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease.
Feuk L; McCarthy S; Andersson B; Prince JA; Brookes AJ
Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):69-71. PubMed ID: 15858821
[TBL] [Abstract][Full Text] [Related]
11. Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.
Blomqvist ME; Silburn PA; Buchanan DD; Andreasen N; Blennow K; Pedersen NL; Brookes AJ; Mellick GD; Prince JA
Neurogenetics; 2004 Jun; 5(2):115-9. PubMed ID: 15088150
[TBL] [Abstract][Full Text] [Related]
12. Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.
Carrasquillo MM; Belbin O; Zou F; Allen M; Ertekin-Taner N; Ansari M; Wilcox SL; Kashino MR; Ma L; Younkin LH; Younkin SG; Younkin CS; Dincman TA; Howard ME; Howell CC; Stanton CM; Watson CM; Crump M; Vitart V; Hayward C; Hastie ND; Rudan I; Campbell H; Polasek O; Brown K; Passmore P; Craig D; McGuinness B; Todd S; Kehoe PG; Mann DM; Smith AD; Beaumont H; Warden D; Holmes C; Heun R; Kölsch H; Kalsheker N; Pankratz VS; Dickson DW; Graff-Radford NR; Petersen RC; Wright AF; Younkin SG; Morgan K
PLoS One; 2010 Jan; 5(1):e8764. PubMed ID: 20098734
[TBL] [Abstract][Full Text] [Related]
13. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
Vepsäläinen S; Parkinson M; Helisalmi S; Mannermaa A; Soininen H; Tanzi RE; Bertram L; Hiltunen M
J Med Genet; 2007 Sep; 44(9):606-8. PubMed ID: 17496198
[TBL] [Abstract][Full Text] [Related]
14. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease.
Zou F; Carrasquillo MM; Pankratz VS; Belbin O; Morgan K; Allen M; Wilcox SL; Ma L; Walker LP; Kouri N; Burgess JD; Younkin LH; Younkin SG; Younkin CS; Bisceglio GD; Crook JE; Dickson DW; Petersen RC; Graff-Radford N; Younkin SG; Ertekin-Taner N
Neurology; 2010 Feb; 74(6):480-6. PubMed ID: 20142614
[TBL] [Abstract][Full Text] [Related]
15. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people.
Florez JC; Wiltshire S; Agapakis CM; Burtt NP; de Bakker PI; Almgren P; Bengtsson Boström K; Tuomi T; Gaudet D; Daly MJ; Hirschhorn JN; McCarthy MI; Altshuler D; Groop L
Diabetes; 2006 Jan; 55(1):128-35. PubMed ID: 16380485
[TBL] [Abstract][Full Text] [Related]
16. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
[TBL] [Abstract][Full Text] [Related]
17. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.
Gu HF; Efendic S; Nordman S; Ostenson CG; Brismar K; Brookes AJ; Prince JA
Diabetes; 2004 Aug; 53(8):2137-42. PubMed ID: 15277398
[TBL] [Abstract][Full Text] [Related]
18. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
Björk BF; Katzov H; Kehoe P; Fratiglioni L; Winblad B; Prince JA; Graff C
Neurobiol Aging; 2007 Sep; 28(9):1374-80. PubMed ID: 16876916
[TBL] [Abstract][Full Text] [Related]
19. Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.
Edland SD
J Mol Neurosci; 2004; 23(3):213-7. PubMed ID: 15181249
[TBL] [Abstract][Full Text] [Related]
20. Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.
Mueller JC; Riemenschneider M; Schoepfer-Wendels A; Gohlke H; Konta L; Friedrich P; Illig T; Laws SM; Förstl H; Kurz A
Neurobiol Aging; 2007 May; 28(5):727-34. PubMed ID: 16675064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
